Literature DB >> 12969347

Factors associated with quality of life in Menière's disease.

L Yardley1, B Dibb, G Osborne.   

Abstract

The aim of this study was to identify the factors associated with better or worse quality of life in a sample of people with Menière's disease drawn from a UK self-help group (the Menière's Society) and to assess the forms of support on which the respondents could draw. A postal survey was sent to 1000 randomly selected group members, containing validated questionnaires assessing: (1) quality of life (the Short Form 36 (SF-36)); (2) factors that might predict quality of life; and (3) usage of resources provided to members by the Menière's Society. A total of 509 members completed the main survey, and 370 the second part of the survey. Factors associated with a less good quality of life included more severe vertigo, pressure in the ear, hearing loss and tinnitus, being younger, being female, living alone, having a lower occupational status and believing that the attitude of the consultant is unhelpful. Levels of vertigo severity in this sample were similar to those found in hospital samples, but it is possible that these respondents may differ in other respects from patients who do not join a self-help group.

Entities:  

Mesh:

Year:  2003        PMID: 12969347     DOI: 10.1046/j.1365-2273.2003.00740.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  11 in total

Review 1.  Vestibular dysfunction: prevalence, impact and need for targeted treatment.

Authors:  Yuri Agrawal; Bryan K Ward; Lloyd B Minor
Journal:  J Vestib Res       Date:  2013       Impact factor: 2.435

2.  Patient Perceptions of Effectiveness in Treatments for Menière's Disease: a National Survey in Italy.

Authors:  Bryan Ward; Vincent Wettstein; John Golding; Giulia Corallo; Daniele Nuti; Franco Trabalzini; Marco Mandala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

3.  Tinnitus and Ménière's disease: characteristics and prognosis in a tinnitus clinic sample.

Authors:  C Herraiz; M C Tapia; G Plaza
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-24       Impact factor: 2.503

4.  The Weather and Ménière's Disease: A Longitudinal Analysis in the UK.

Authors:  Wiebke Schmidt; Christophe Sarran; Natalie Ronan; George Barrett; David J Whinney; Lora E Fleming; Nicholas J Osborne; Jessica Tyrrell
Journal:  Otol Neurotol       Date:  2017-02       Impact factor: 2.311

5.  Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study.

Authors:  Ovidiu Băjenaru; Adina Maria Roceanu; Silviu Albu; Viorel Zainea; Alexandru Pascu; Mădălina Gabriela Georgescu; Sebastian Cozma; Luigi Mărceanu; Dafin Fior Mureşanu
Journal:  Int J Gen Med       Date:  2014-12-04

6.  Graphic representation of the burden of suffering in dizziness patients.

Authors:  Steffi Weidt; Annette Beatrix Bruehl; Hanspeter Moergeli; Dominik Straumann; Stefan Hegemann; Stefan Büchi; Michael Rufer
Journal:  Health Qual Life Outcomes       Date:  2014-12-19       Impact factor: 3.186

Review 7.  Effects of intratympanic gentamicin and intratympanic glucocorticoids in Ménière's disease: a network meta-analysis.

Authors:  Weiming Hao; Huiqian Yu; Huawei Li
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

8.  Health-related quality of life and emotional distress in patients with dizziness: a cross-sectional approach to disentangle their relationship.

Authors:  Steffi Weidt; Annette B Bruehl; Dominik Straumann; Stefan C A Hegemann; Gerhard Krautstrunk; Michael Rufer
Journal:  BMC Health Serv Res       Date:  2014-07-22       Impact factor: 2.655

9.  Impact evaluation and association with EuroQol 5D health-related utility values in Ménière's disease.

Authors:  Ilmari Pyykkő; Vinaya Manchaiah; Hilla Levo; Erna Kentala
Journal:  Springerplus       Date:  2015-11-24

10.  Treatment of vestibular disorders with weak asymmetric base-in prisms: An hypothesis with a focus on Ménière's disease.

Authors:  Jelte E Bos; Astrid J A Lubeck; P Eric M Vente
Journal:  J Vestib Res       Date:  2018       Impact factor: 2.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.